the latest update of COVAX supply forecast indicates that a total of approximately 1.4 billion doses are the most realistic target achievable for 2021.
Nigeria might have to develop a stronger strategy to acquire COVID-19 vaccines outside the COVAX as export restrictions in India, scale-up hurdles at manufacturing sites and regulatory bureaucracies have forced the global scheme to cut its 2021 supply forecast by 25 percent.
The World Health Orga
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
